pocketful logo light
pocketful logo light
Samrat Pharmachem Ltd logo

Samrat Pharmachem Ltd

NSE: BSE: 530125

₹225.95

(0.67%)

Wed, 23 Sept 2026, 10:23 pm

mtf coin illustrationMTF 5x

Samrat Pharmachem Share Price Live Chart

1 Day

(0.67%)

No Result Found

Summary

  • Market Cap (in Cr)

    76.9

  • Net Profit (in Cr)

    7.11

  • P/B

    1.35

  • Sector P/E

    44.89

  • P/E

    13.59

  • EV/EBITDA

    9.50

  • Debt/Equity (Industry)

    0.17

  • Interest Cover (Industry)

    18.17

  • ROCE (Industry)

    20.59

  • RONW (Industry)

    17.62

  • ROE

    10.39

  • ROCE

    13.60

  • Debt/Equity

    0.13

  • EPS (TTM)

    0

  • Dividend Yield

    0.40

  • Book Value

    228.74

  • Interest Cover

    15.75

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters49.0949.0949.0949.0949.09
FII00000
DII0003.240
Public50.9150.9150.9147.6750.91
Government00000

Read More

Technical Analysis

RSI

42.98

MACD

-3.96

50 DMA

240.15

200 DMA

224.96

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic305.48273.53257.12241.58225.17209.63177.68
Fibonacci273.53261.33253.79241.58229.38221.84209.63
Camarilla249.49246.56243.63241.58237.77234.84231.91

Pivots Level: Classic

R3

+63.90

305.48

R2

+31.95

273.53

R1

+15.53

257.12

241.58
241.58
Pivot Point
LTP: 224.90

S1

-16.42

225.17

S2

-31.95

209.63

S3

-63.90

177.68

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    227.33

  • 20-EMA

    230.47

  • 30-EMA

    232.67

  • 50-EMA

    234.00

  • 100-EMA

    233.04

  • 200-EMA

    242.26

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
30 May 2026board-meetingsAccounts
13 Feb 2026board-meetingsQuarterly Results
14 Nov 2025board-meetingsQuarterly Results
18 Aug 2025dividendFinal Dividend - Rs. - 118 Sept 2025
30 May 2025dividend₹1.00 Dividend /Share18 Sept 2025
30 May 2025agm
19 Aug 2024dividendFinal Dividend - Rs. - 119 Sept 2024
30 May 2024dividend₹1.00 Dividend /Share19 Sept 2024
30 May 2024agm
18 Aug 2023dividendDividend - Rs. - 118 Sept 2023

Read More

Peer Comparison

Samrat Pharmachem Ltd logo

Samrat Pharmachem Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Read More

Samrat Pharmachem Ltd About

Samrat Pharmachem is principal activities are manufacturing and selling chemicals. The shares of the Company are listed on stock exchanges in India.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1992

Headquarters

CEO

Lalit Mehta

Employees

Contact

Website icon

Website

http://www.samratpharmachem.com

Email icon

Email

contact@samratpharmachem.in

Phone icon

Phone

91-2646-220774

Location icon

Location

Plot No A2/3445, GIDC Phase IV, Ankleshwar, Gujarat, 393002

Read More

Samrat Pharmachem Ltd Company History

YearHistory
1994
  • The Company achieved a turnover of Rs.153.51 lacs and cash profit of Rs 8.79 lacs during the five month period ended 31st August.
  • The Company achieved direct and indirect exports worth Rs.35.59 lacs for the year ended March.
  • The Company achieved direct exports worth Rs.12.24 lacs from April to August.
2008
  • The company introduced an E-mail ID for Investors Complaints: [email protected]
2013
  • Samrat Pharmachem Ltd changed its Corporate Office Address to 701 / 702, Business Square, M. A. Road, Andheri (West), Mumbai - 400058.
2021
  • SPL received Authorized Economic Operator (AEO) Certificate from Indian Customs.
2023
  • SPL received FDA Licence.
  • SPL received Good Manufacturing Practices (GMP) & Good Laboratory Practices (GLP) Certificates from FDA.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GOLECHHA GLOBAL FINANCE LIMITEDbulkSell16000426.1609 Sept 2024
SETU SECURITIES PVT. LTD.bulkSell15602341.6507 Aug 2023
SETU SECURITIES PVT. LTD.bulkBuy15602344.4307 Aug 2023
ALERT CONSULTANTS & CREDIT PRIVATE LIMITEDbulkSell21769345.7407 Aug 2023
GOLECHHA GLOBAL FINANCE LIMITEDbulkSell23630405.8227 Jul 2023
HARISHKUMARGUPTAbulkBuy22000629.218 Aug 2022
MALA R BHAVNANIbulkSell28294454.5310 Jan 2022
ADVANI PRIVATE LIMITEDbulkBuy68000404.2207 Jan 2022
MALA R BHAVNANIbulkSell78000404.4507 Jan 2022
TINA GOYALbulkBuy18800322.5223 Dec 2021

Read More

Samrat Pharmachem Ltd News

Samrat Pharmachem appoints statutory auditors for 5 years

Samrat Pharmachem Ltd appointed Divyesh J Shah & Associates as statutory auditors for five years, subject to shareholder approval.

17 Jul 2026

companies

Samrat Pharmachem Files FY26 Audited Results in Newspapers

Samrat Pharmachem Limited published an extract of its standalone audited financial results for the quarter and year ended March 31, 2026 in newspapers on June 2, 2026, as required under SEBI LODR Regulation 47.

04 Jun 2026

companies

Samrat Pharmachem Declares Non-Large Corporate Status

Samrat Pharmachem Limited confirms it does not meet SEBI's Large Corporate criteria under circular SEBI/HO/DDHS/CIR/P/2018/144, maintaining compliance with regulatory disclosure requirements.

07 Apr 2026

companies

Samrat Pharmachem Submits Q4FY26 SEBI Certificate

Samrat Pharmachem Limited submitted its quarterly certificate under SEBI Regulation 74(5) for Q4FY26, confirming compliance with dematerialisation requirements through registrar MUFG Intime India.

07 Apr 2026

companies

Samrat Pharmachem Gets Credit Rating Upgrade from Crisil

Crisil Limited has upgraded Samrat Pharmachem Limited's credit rating on bank facilities to 'Crisil BB/Stable/Crisil A4+' from 'Crisil BB+/Negative/Crisil A4+', reflecting improved financial outlook.

30 Mar 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Samrat Pharmachem Ltd?

    As of 24/09/2026 at 3:53 AM, Samrat Pharmachem Ltd shares are trading at ₹225.95.

  • 2.What is the market cap. of Samrat Pharmachem Ltd?

    As of 24/09/2026, the market capitalization of Samrat Pharmachem Ltd is ₹69.35 crore.

  • 3.When was Samrat Pharmachem Ltd founded?

    Samrat Pharmachem Ltd was founded in 1992.

  • 4.How can I buy shares of Samrat Pharmachem Ltd?

    You can buy shares of Samrat Pharmachem Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 5.Does Samrat Pharmachem Ltd pay dividends?

    Yes, Samrat Pharmachem Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 1 per share.

  • 6.What is the dividend yield of Samrat Pharmachem Ltd?

    As of 24 September, 2026, the dividend yield of Samrat Pharmachem Ltd stands at 0.45%.

  • 7.What are the latest financial results of Samrat Pharmachem Ltd?

    For January,2024, Samrat Pharmachem Ltd reported revenue of ₹286.00 crore and a net profit of ₹7.11 crore.

  • 8.Who is the CEO of Samrat Pharmachem Ltd?

    The CEO of Samrat Pharmachem Ltd is Lalit Mehta.

Open Your Free Demat Account

Enter your phone number